Objectives:
Early detection of Hepatitis B Virus (HBV) is essential for effective disease management, particularly in resource-limited regions such as Enugu State, Nigeria. This study aimed to develop a predictive model for HBV status based on gender and selected serum biomarkers— alpha glutathione S-transferase (GST), Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), and Alkaline Phosphatase (ALP)—in patients at Enugu State University Teaching Hospital.
Design & Methods:
A binary logistic regression model was used to analyze the predictive power of gender and serum biomarkers (alpha GST, AST, ALT, and ALP) in determining HBV status. Statistical significance was evaluated with Chi-Square tests, and Wald values was used to assess the strength of association. The odds ratio (OR) was calculated to quantify the likelihood of HBV prediction based on each variable.
Results:
Among the analyzed variables, only AST emerged as a significant predictor of HBV status, yielding a Chi-Square value of 93.939 with 5 degrees of freedom (p < .001), a Wald statistic of 32.894, and an odds ratio of 0.895. In contrast, gender, alpha GST, ALP, and ALT did not demonstrate statistical significance in predicting HBV status within the model.
Conclusions:
The findings underscore AST as a critical biomarker for predicting HBV, with limited predictive utility observed for gender, alpha GST, ALP, and ALT. This model could facilitate early HBV detection and timely intervention, particularly in resource-constrained settings, contributing to improved patient outcomes.